The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status

Activated Ras signaling significantly enhances reovirus replication and spread

(2009) M Shmulevitz et al.   CANCER GENE THERAPY

Induction of Alpha/Beta Interferon by Myxoma Virus Is Selectively Abrogated When Primary Mouse Embryo Fibroblasts Become Immortalized

(2009) F. Wang et al.   JOURNAL OF VIROLOGY

Myxoma virus targets primary human leukemic stem and progenitor cells while sparing normal hematopoietic stem and progenitor cells

(2009) M Kim et al.   LEUKEMIA

Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling

(2008) S. Bea et al.   BLOOD

Reovirus infection of cancer cells is not due to activated Ras pathway

(2008) L Song et al.   CANCER GENE THERAPY

A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer

(2008) L. Vidal et al.   CLINICAL CANCER RESEARCH

Transcriptional role of p53 in interferon-mediated antiviral immunity

(2008) César Muñoz-Fontela et al.   JOURNAL OF EXPERIMENTAL MEDICINE

A Phase I Trial of Intratumoral Administration of Reovirus in Patients With Histologically Confirmed Recurrent Malignant Gliomas

(2008) Peter Forsyth et al.   MOLECULAR THERAPY

Myxoma Virus Oncolysis of Primary and Metastatic B16F10 Mouse Tumors In Vivo

(2007) Marianne M Stanford et al.   MOLECULAR THERAPY